Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial uncoupling protein 2 (UCP2) mRNA encodes a protein that belongs to the mitochondrial anion carrier superfamily (SLC25 family), specifically located in the inner mitochondrial membrane (UniProt P55851). The primary biological function of the encoded protein is to facilitate a proton leak, which uncouples oxidative phosphorylation from ATP synthesis, thereby regulating the mitochondrial membrane potential and limiting the production of reactive oxygen species (ROS) (NCBI Gene: 7351). In disease states, UCP2 mRNA is often upregulated; in pancreatic beta cells, this leads to impaired glucose-stimulated insulin secretion, contributing to the development of type 2 diabetes (PMID: 16054071). Additionally, UCP2 is frequently overexpressed in various cancers, where it promotes chemoresistance by suppressing ROS-induced apoptosis and facilitating metabolic shifts (PMID: 21115568). Therapeutic strategies targeting UCP2 mRNA, such as siRNA or antisense oligonucleotides, aim to downregulate protein levels to restore insulin sensitivity or sensitize malignant cells to oxidative stress-inducing therapies, though care must be taken to avoid systemic oxidative damage.
Targeting UCP2 mRNA typically involves RNA interference (siRNA) or antisense oligonucleotides (ASOs) to induce degradation of the transcript or block its translation, thereby reducing the expression of the UCP2 protein and subsequently increasing mitochondrial membrane potential and ROS production.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial uncoupling protein 2 mRNA (UCP2 mRNA).